# Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/telitacicept-for-iga-nephropathy-interim-analysis-of-a-phase-3-trial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jicheng Lv,Lijun Liu,Wenxiang Wang,X M Wang,Qing Zuraw,V Perkovic,Jianmin Fang,Hong Zhang |
| Citations | 4 |
| DOI | 10.1056/nejmoa2514415 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W7161047515 |
| PMID | 42127391 |
| Type | article |
| Year | 2026 |

## Paper authors

- [V Perkovic](https://scholariq.org/researchers/v-perkovic/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.